Whole genome sequencing and single-cell transcriptomics identify KMT2D inactivation as a potential new driver for pituitary tumors: a case report
Abstract The pituitary gland is a main component of the endocrine system and a master controller of hormone production and secretion. Unlike neoplastic formation in other organs, Pituitary Neuroendocrine Tumors (PitNETs) are frequent in the population (16%) and, for unknown reasons, almost never met...
Saved in:
| Main Authors: | Maxime Brunner, Jenny Meylan-Merlini, Maude Muriset, Sergey Oreshkov, Andrea Messina, Mahmoud Messerer, Roy Daniel, Ekkehard Hewer, Jean Phillipe Brouland, Federico Santoni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-06-01
|
| Series: | BJC Reports |
| Online Access: | https://doi.org/10.1038/s44276-025-00155-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A whole-organism landscape of X-inactivation in humans
by: Bjorn Gylemo, et al.
Published: (2025-07-01) -
KMT2A-rearranged acute lymphoblastic leukaemia
by: Rishi S. Kotecha, et al.
Published: (2024-12-01) -
Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes
by: Lisa Dietsche, et al.
Published: (2025-01-01) -
Nutritional evaluation of inactivated whole soy and protease enzyme for growing and finishing pigs
by: M.R. Carmo, et al.
Published: (2025-01-01) -
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients
by: Maximilian N. Kinzler, et al.
Published: (2025-05-01)